Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReabold Resources Regulatory News (RBD)

Share Price Information for Reabold Resources (RBD)

Share Price is delayed by 15 minutes
Get Live Data
83.50    -0.50 (-0.60%)
Bid:
82.00
Ask:
85.00
Spread: 3.00 (3.659%)
Market Cap: £12.11m
RBD Live PriceLast checked at - London Stock Exchange

Intraday Reabold Resources Share Chart

Acquisition

6 Feb 2007 07:00

Adventis Group PLC06 February 2007 For release at 07.00 Feb 6th 2007 ADVENTIS GROUP PLC ACQUISITION OF LEAPFROG MEDICAL COMMUNICATIONS LTD Adventis Group plc ( "Adventis" or the "Company", ticker ATG), the specialistmultimedia and marketing group, is pleased to announce that it has acquiredLeapFrog Medical Communications Limited ("LeapFrog"), a leading medicaleducation company, for a total maximum consideration of £2.65 million. The total consideration will be satisfied by the payment of initialconsideration of £1.306 million, payable as to £0.874 million in cash and £0.432million by the issue of 975,169 new ordinary shares in Adventis ("New OrdinaryShares"), and by deferred consideration of £0.72 million payable in tranches of£0.24 million on each of the first, second and third anniversaries of theacquisition. Each deferred consideration tranche will be satisfied as to 60 percent in cash and as to 40 per cent payable in new ordinary shares in Adventis.There is further deferred consideration payable of up to £0.624 million, basedon the achievement of certain profit growth related criteria over the followingthree years to be satisfied annually according to performance as to 50 per centin cash and 50 per cent payable in new ordinary shares in Adventis. LeapFrog, whose clients include, GSK, Pfizer, MSD, Roche and Novartis, wasestablished in 2001. It provides a range of medical education programmes to thehealthcare industry, promotional aids for sales representatives and alsoinitiates PR campaigns aimed at healthcare professionals and consumers forimproving clients' product brand awareness. For the year ended 30 November 2006,LeapFrog reported audited turnover of approximately £1.57 million and pre-taxprofit of approximately £0.39 million. Net assets at that date amounted toapproximately £0.25 million. Tim Schofield and Gail Rowe, LeapFrog's principaldirectors, will remain with the company following the acquisition. The acquisition will create one of the industry's top three pharmaceuticalindustry service providers, becoming part of an enlarged Healthcare servicesdivision embracing Affiniti Advertising, acquired in 2005, and RoundhouseHealthAd, acquired in 2006. The addition of LeapFrog to Affiniti and Roundhouse creates a formidable,award-winning team in the Adventis Healthcare division, with over 50 employeesworking in centralised premises in the Thames Valley. The enlarged Healthcareservices operations, whose other clients include Boehringer Ingelheim, Allergan,Baxter and Merck Serono, will have the capability to provide a complete range ofintegrated marketing services, from medical education, to advertising to newmedia. It will also provide the opportunity for an increased level ofcross-selling and the ability to provide multinational clients with a greaterlocal understanding of target markets service. Application has been made for the admission to AIM of the New Ordinary Shares,which will rank pari passu with the Company's existing issued ordinary shares,and dealings are expected to commence on 9th February 2007. Charles Phillpot, CEO, Adventis Group, said: "We will now be one of the fewcompanies in the industry to offer a full service marketing capability and theability to handle larger and more complex campaigns for clients. We are nowamong the top three players in two of our three chosen market sectors." Tim Schofield and Gail Rowe said: "We see joining forces with the two topcreative agencies in our industry as a unique way of adding value to ourclients. Being able to address their various needs within one group will be atremendous bonus for us all." ENDS Enquiries: Adventis Group Plc Charles Phillpot, CEO 020 7034 4750 Peter Linnell, Finance Director & Company Secretary 020 7034 4795 Adventis Financial PR Chris Steele 020 7034 4759 Peter Binns 020 7034 4760 Editor's Note: Adventis Group plc, provides a complete range of communications services,including corporate identity programmes, advertising campaigns, media andplanning and buying, literature, public relations, packaging, exhibitions,research and planning, interiors signage and digital media. The group employs145 staff in London and the southeast. Adventis has two other divisions focusing on providing a range of services tothe property and financial sectors. Adventis Group was admitted to AIM in 2004,mainly operating as a media and marketing services provider to the propertysector. LeapFrog becomes the group's ninth operating company. www.adventis.co.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
22nd Aug 20197:00 amRNSIncreased Investment in Rathlin Energy
12th Aug 201910:04 amRNSOperational Update at West Newton, onshore UK
7th Aug 20197:00 amRNSSpudding of the Iecea Mica-1 Well, Parta, Romania
6th Aug 20197:00 amRNSCapital Reduction Update
31st Jul 20197:00 amRNSCorallian Energy Limited Update
30th Jul 20191:54 pmRNSResult of Annual General Meeting
29th Jul 20197:00 amRNSOperational Update
17th Jul 20197:00 amRNSCompletion of Parta Exploration Licence Farm-In
12th Jul 20192:23 pmRNSHolding(s) in Company
9th Jul 20194:47 pmRNSHolding(s) in Company
8th Jul 20191:46 pmRNSCorrection to Notice of Annual General Meeting
2nd Jul 20193:37 pmRNSNotice of AGM and Proposed Capital Reduction
2nd Jul 20197:00 amRNSPlacing to raise £2.65 million
28th Jun 20194:19 pmRNSPosting of Annual Report and Accounts
27th Jun 20197:00 amRNSFull Year Results for year ended 31 December 2018
21st Jun 20192:05 pmRNSSecond Price Monitoring Extn
21st Jun 20192:00 pmRNSPrice Monitoring Extension
19th Jun 20197:00 amRNSWest Newton A-2 appraisal well
18th Jun 20197:00 amRNSOperations Update at Iecea Mica-1, Romania
17th Jun 20192:05 pmRNSSecond Price Monitoring Extn
17th Jun 20192:00 pmRNSPrice Monitoring Extension
17th Jun 20197:00 amRNSDiscovery Potentially Largest UK Onshore Gas Field
5th Jun 20197:00 amRNSCorallian Energy - Award of Five Licences
30th May 20197:00 amRNSParta Well Appraisal Operations Update
20th May 20197:00 amRNSReabold California Operational Update
9th May 20197:00 amRNSIncreased Investment in Danube Petroleum
29th Apr 20197:00 amRNSReabold California Operational Update
26th Apr 20197:00 amRNSWell commencement at West Newton, onshore UK
16th Apr 20197:00 amRNSWest Brentwood Operations Update
8th Apr 20197:00 amRNSParta Exploration Licence Farm-In
1st Apr 20197:00 amRNSSecond Oil Discovery at Monroe Swell
25th Mar 20197:00 amRNSRig Contract Signed for West Newton Well
22nd Mar 20197:00 amRNSSpudding of Second Well at Monroe Swell
19th Mar 20197:00 amRNSParta Appraisal Operations Update
11th Mar 20197:00 amRNSOil Discovery at Monroe Swell
8th Mar 20197:00 amRNSCompletion of Colter Drilling
8th Mar 20197:00 amRNSCompletion of Colter Drilling
4th Mar 20197:00 amRNSReabold California Update
25th Feb 20197:00 amRNSColter South Oil Discovery and Forward Plan
25th Feb 20197:00 amRNSColter South Oil Discovery and Forward Plan
8th Feb 20193:00 pmRNSIssue of Shares
6th Feb 201911:40 amRNSCommencement of drilling operations at Colter
1st Feb 20197:00 amRNSPresentation at Investor Evening
28th Jan 20197:00 amRNSProduction test at VG-4 Well, West Brentwood
16th Jan 20197:00 amRNSWick Well Result
3rd Jan 20197:00 amRNSSuccessful Result at VG-4 Well, West Brentwood
27th Dec 20187:00 amRNSSpudding of the Wick well
19th Dec 201810:06 amRNSRig Mobilised for UK Drilling Campaign
19th Dec 20187:00 amRNSCommencement of VG-4 Well, West Brentwood Licence
11th Dec 201811:15 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.